Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage

被引:84
作者
Vergne, L
Bourgeois, A
Mpoudi-Ngole, E
Mougnutou, R
Mbuagbaw, J
Liegeois, F
Laurent, C
Butel, C
Zekeng, L
Delaporte, E
Peeters, M
机构
[1] IRD, UR36, Retrovirus Lab, F-34394 Montpellier 5, France
[2] Mil Hosp, Project Presica, Yaounde, Cameroon
[3] Lab Hyg Mobile, Yaounde, Cameroon
关键词
HIV-1; variants; Cameroon; intergroup recombinant; dual infection; syncytium-inducing phenotype; IMMUNODEFICIENCY-VIRUS TYPE-1; AMINO-ACID-SEQUENCE; WEST-CENTRAL-AFRICA; CELL TROPISM; SUBTYPE; IDENTIFICATION; TRANSMISSION; PROGRESSION; DIVERSITY; AIDS;
D O I
10.1016/S0042-6822(03)00167-3
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In Yaounde, Cameroon, HIV-1 group-specific V3 serology on 1469 HIV-positive samples collected between 1996 and 2001 revealed that group O infections remained constant around 1% for 6 years. Only one group N sample was identified and 4.3% reacted with group M and O peptides. Although the sensitivity of the group-specific polymerase chain reaction (PCR) in two genomic regions was not optimal, we confirmed, in at least 6 of 49 (12.2%) dual O/M seropositive samples and in 1 of 9 group 0 samples, dual infection with group O and M viruses (n = 4) or with group O or M virus and an intergroup recombinant virus (n = 3). Partial em, (V3-V5) sequences on a Subset of 295 samples showed that at least eight subtypes and five circulating recombinant forms (CRFs) of HIV-1 group M co-circulate; more than 60% were CRF02_AG and 11% had discordant subtype/CRF designations between el7v and gag. Similarly as for subtype B. the proportion of syncytium-inducing strains increased when CD4 counts were low in CRF02_AG-infected patients. The V3-loop charge was significantly lower for non-syncytium-inducing strains than for syncytium-inducing strains but cannot be used as an individual marker to predict phenotype. The two predominant HIV-1 variants in Africa, CRF02_AG and subtype C, thus have different biological characteristics. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:254 / 266
页数:13
相关论文
共 66 条
[1]  
[Anonymous], HIV SEQUENCE COMPEND
[2]   Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility [J].
Apetrei, C ;
Descamps, D ;
Collin, G ;
Loussert-Ajaka, I ;
Damond, F ;
Duca, M ;
Simon, F ;
Brun-Vézinet, F .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3534-3538
[3]   Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions [J].
Apetrei, C ;
LoussertAjaka, I ;
Descamps, D ;
Damond, F ;
Saragosti, S ;
BrunVezinet, F ;
Simon, F .
AIDS, 1996, 10 (14) :F57-F60
[4]   HIV-1 group N among HIV-1-seropositive individuals in Cameroon [J].
Ayouba, A ;
Souquières, S ;
Njinku, B ;
Martin, PMV ;
Müller-Trutwin, MC ;
Roques, P ;
Barré-Sinoussi, F ;
Mauclère, P ;
Simon, F ;
Nerrienet, E .
AIDS, 2000, 14 (16) :2623-2625
[5]   HIV-1 group O infection in Cameroon, 1986-1998 [J].
Ayouba, A ;
Mauclère, P ;
Martin, PMV ;
Cunin, P ;
Mfoupouendoun, J ;
Njinku, B ;
Souquières, S ;
Simon, F .
EMERGING INFECTIOUS DISEASES, 2001, 7 (03) :466-467
[6]   Short communication - Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries [J].
Bibollet-Ruche, F ;
Peeters, M ;
Mboup, S ;
Ekaza, E ;
Gandji, R ;
Torimiro, J ;
Mpoudi, EN ;
Amblard, J ;
Dibanga, G ;
Saidou, M ;
Esu-Williams, E ;
Haesevelde, MV ;
Saman, E ;
Delaporte, E .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (14) :1281-1285
[7]   Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients [J].
Björndal, Å ;
Sönnerborg, A ;
Tscherning, C ;
Albert, J ;
Fenyö, EM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (07) :647-653
[8]   The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon [J].
Carr, JK ;
Torimiro, JN ;
Wolfe, ND ;
Eitel, MN ;
Kim, B ;
Sanders-Buell, E ;
Jagodzinski, LL ;
Gotte, D ;
Burke, DS ;
Birx, DL ;
McCutchan, FE .
VIROLOGY, 2001, 286 (01) :168-181
[9]   SYNCYTIUM-INDUCING (SI) PHENOTYPE SUPPRESSION AT SEROCONVERSION AFTER INTRAMUSCULAR INOCULATION OF A NON-SYNCYTIUM-INDUCING/SI PHENOTYPICALLY MIXED HUMAN-IMMUNODEFICIENCY-VIRUS POPULATION [J].
CORNELISSEN, M ;
MULDERKAMPINGA, G ;
VEENSTRA, J ;
ZORGDRAGER, F ;
KUIKEN, C ;
HARTMAN, S ;
DEKKER, J ;
VANDERHOEK, L ;
SOL, C ;
COUTINHO, R ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1995, 69 (03) :1810-1818
[10]   EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC [J].
DECOCK, KM ;
ADJORLOLO, G ;
EKPINI, E ;
SIBAILLY, T ;
KOUADIO, J ;
MARAN, M ;
BRATTEGAARD, K ;
VETTER, KM ;
DOORLY, R ;
GAYLE, HD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (17) :2083-2086